nach oben

Reactions Weekly

Erschienen in:

01.12.2017 | Case report

Risperidone

Hyperprolactinaemia successfully treated with aripiprazole: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Excerpt

A 41-year-old man developed hyperprolactinaemia during treatment with risperidone [route, dosage, indication and duration of treatment to reaction onset not stated]. He was successfully treated with aripiprazole [outcome not stated]. …

Sundar A, et al. Role of aripiprazole in the treatment of risperidone-induced hyperprolactinemia-a case report and literature review. CNS Spectrums 22: 66 abstr. 107, No. 1, Feb 2017. Available from: URL: http://doi.org/10.1017/S1092852916000900 [abstract] - USA

Titel: Risperidone
Hyperprolactinaemia successfully treated with aripiprazole: case report
Publikationsdatum: 01.12.2017
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2017
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-017-39229-5

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Risperidone

Hyperprolactinaemia successfully treated with aripiprazole: case report

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2017

Everolimus/methylprednisolone

Multiple drugs

Leflunomide/methotrexate

Prednisone/tacrolimus

Microfibrillar-collagen-haemostat

Citalopram/omeprazole interaction